The global Alopecia Treatment Market is estimated to be valued at US$ 9.65 Bn in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Alopecia Treatment Market comprises of several treatment options meant to either halt hair loss or restore lost hair. Treatment options for alopecia covers conventional therapies like topical and oral medications as well as emerging targeted approaches like low-level laser therapy. Targeted approaches offer precision and effectiveness over conventional therapies.
Market key trends:
One of the key trends fueling the growth of the alopecia treatment market is the rising adoption of targeted approaches like low-level laser therapy. This non-invasive hair loss treatment uses application of low-level laser energy on the scalp to stimulate hair follicles and promote hair growth. Studies have proved its effectiveness in treating both androgenic alopecia and alopecia areata. Low-level laser therapy has gained popularity as it is needle-free, painless and shows tangible results within 3 to 6 months of treatment regime. Its precision and effectiveness over conventional therapies has driven its uptake in the alopecia treatment market.
Segment Analysis
The global alopecia treatment market is segmented into alopecia areata, androgenic alopecia, alopecia totalis, and others. Androgenic alopecia dominates the market and accounts for the largest share. Androgenic alopecia or male/female pattern baldness is a common form of hair loss that affects millions of men and women each year. The rising prevalence of androgenic alopecia globally due to increasing stress levels and unhealthy lifestyle habits drives the growth of this segment.
Key Takeaways
The Global Alopecia Treatment Market Share is expected to witness high growth, exhibiting a CAGR of 5.6% over the forecast period, due to increasing awareness about hair loss treatments and the rising geriatric population.
Regional Analysis
North America dominates the alopecia treatment market due to the rising awareness about hair loss treatments and presence of major market players in the region. Europe holds the second largest share in the alopecia treatment market due to rising geriatric population and increasing cases of hair fall related issues. Asia Pacific exhibits the fastest growth over the forecast period owing to growing disposable income, improving healthcare infrastructure, and increasing research activities for alopecia treatment.
Key Players
Key players operating in the alopecia treatment market are Stemson Therapeutics, OliX Pharmaceuticals, Inc, Pfizer Inc, Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy’s Laboratories Ltd., Himalaya Wellness Company, Stemson Therapeutics, Cosmo Pharmaceuticals N.V., Equillium, Inc., Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.
Get More Insights Here
https://healthcarelatesteditionnews.blogspot.com/2023/12/targeted-approaches-are-fastest-growing.html
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian